Prevention and treatment of major blood loss.
Detry
Olivier
O
De Roover
Arnaud
A
Honoré
Pierre
P
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005167:Factor VII / Q000191:economics / Q000627:therapeutic use*; D015942:Factor VIIa; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D033221:Jehovah's Witnesses; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa